Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (2016 - 2025)

MedWellAI (MWAI) has disclosed Shares Outstanding for 9 consecutive years, with $130000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 97.52% to $130000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $130000.0, a 97.52% decrease, with the full-year FY2025 number at $3000.0, down 99.94% from a year prior.
  • Shares Outstanding was $130000.0 for Q4 2025 at MedWellAI, down from $6.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $6.2 million in Q3 2025 to a low of $1125.0 in Q3 2021.
  • A 5-year average of $1.0 million and a median of $500000.0 in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: soared 147275.38% in 2022, then crashed 99.94% in 2025.
  • MedWellAI's Shares Outstanding stood at $205.1 million in 2021, then plummeted by 99.02% to $2.0 million in 2022, then crashed by 93.52% to $130000.0 in 2023, then soared by 3928.14% to $5.2 million in 2024, then plummeted by 97.52% to $130000.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Shares Outstanding are $130000.0 (Q4 2025), $130000.0 (Q3 2025), and $3000.0 (Q2 2025).